AÑora, Maylen .
HRN: 28-90-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2026
CEFUROXIME 500MG (TAB)
04/25/2026
05/01/2026
PO
500MG
BID
Sp NSVD: Thinly MSaf
Checking Initial Appropriateness